Holen Sie sich die Stockscreener-App
6.665
1.26%
-0.085
Handel nachbörslich:
6.67
0.005
+0.08%
Schlusskurs vom Vortag:
$6.75
Offen:
$6.791
24-Stunden-Volumen:
7,786
Relative Volume:
1.14
Marktkapitalisierung:
$60.15M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.49%
1M Leistung:
-2.42%
6M Leistung:
-9.22%
1J Leistung:
+21.18%
1-Tages-Spanne:
$6.665
$6.7949
1-Wochen-Bereich:
$6.45
$6.85
52-Wochen-Spanne:
$3.79
$7.66
Neuehealth Inc Stock (NEUE) Company Profile
Firmenname
Neuehealth Inc
Sektor
Branche
Telefon
612-238-1321
Adresse
9250 NW 36TH STREET, DORAL
Vergleichen Sie NEUE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NEUE
Neuehealth Inc
|
6.665 | 60.28M | 0 | 0 | 0 | 0.00 |
|
UNH
Unitedhealth Group Inc
|
271.81 | 228.94B | 422.82B | 21.30B | 25.27B | 23.08 |
|
CVS
Cvs Health Corp
|
65.90 | 82.29B | 386.64B | 4.53B | 4.78B | 3.58 |
|
CI
Cigna Group
|
287.10 | 73.95B | 260.93B | 5.02B | 3.94B | 18.32 |
|
ELV
Elevance Health Inc
|
294.43 | 65.48B | 189.25B | 5.36B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
281.99 | 32.07B | 117.76B | 1.21B | 2.39B | 9.95 |
Neuehealth Inc Stock (NEUE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-10-11 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-03-29 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-03-04 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-03-02 | Herabstufung | BofA Securities | Buy → Underperform |
| 2022-01-10 | Fortgesetzt | Citigroup | Neutral |
| 2021-12-16 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-12-10 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-11-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-02 | Herabstufung | Cowen | Outperform → Market Perform |
| 2021-11-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-08-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-08-04 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-07-19 | Eingeleitet | Goldman | Buy |
| 2021-07-19 | Eingeleitet | JP Morgan | Neutral |
| 2021-07-19 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-19 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-07-19 | Eingeleitet | Wolfe Research | Peer Perform |
Alle ansehen
Neuehealth Inc Aktie (NEUE) Neueste Nachrichten
NeueHealth Inc’s Earnings Call Highlights Growth and Innovation - MSN
How institutional ownership impacts NeueHealth Inc. stockFree Risk-Adjusted Picks With Exit Strategy - Newser
Tools to assess NeueHealth Inc.’s risk profileTechnical Setup Guide for Daily Watchlist - Newser
What makes NeueHealth Inc. stock price move sharplyWeekly Stock Market Strategy Summary - Newser
Will NeueHealth Inc. price bounce be sustainableReal-Time Setup Summary with ROI Focus - Newser
NeueHealth signals ongoing growth with 45% increase in consumers served while expanding NeuePulse platform - MSN
Custom strategy builders for tracking NeueHealth Inc.Predictive Short-Term Market Reversal Alerts - Newser
Buy Signal for NeueHealth Inc. Stock Key Technical Indicators to WatchMomentum Prediction Based on AI Backtesting - Newser
What’s the recovery path for long term holders of NeueHealth Inc.ROI Focused Setup Screener With Exit Markers - Newser
Predicting NeueHealth Inc. trend using moving averagesFree Real Time Trade Opportunity Alerts - Newser
Chart overlay techniques for tracking NeueHealth Inc.Quarterly Investment Outlook and Key Summary - Newser
Will NeueHealth Inc. stock hit new highs in YEARVolume Surge With Low Float - thegnnews.com
NeueHealth Inc. Reports Strong Q2 2025 Results - The Globe and Mail
How high can NeueHealth Inc. stock goFree Smart Trend Trading with Weekly Signals - Newser
NeueHealth 2025 Q2 Earnings Strong Performance as Net Income Losses Drop 97.3% - AInvest
NeueHealth: Q2 Earnings Snapshot - Connecticut Post
NeueHealth Inc (NEUE) Q2 2025 Earnings Call Highlights: Sustained Profitability and Strategic ... By GuruFocus - Investing.com Canada
Tools to monitor NeueHealth Inc. recovery probabilityFree Stock Portfolio Allocation Guidance - Newser
NeueHealth's Q2 2025: Unraveling Contradictions in Growth Strategy, Financial Performance, and Acquisitions - AInvest
Transcript : NeueHealth, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Earnings call transcript: NeueHealth Q2 2025 sees steady growth amid strategic initiatives - Investing.com Canada
Earnings call transcript: NeueHealth Q2 2025 sees steady growth amid strategic initiatives By Investing.com - Investing.com South Africa
NeueHealth reports Q2 EPS ($2.62) vs. ($8.65) last year - TipRanks
NeueHealth reports second quarter 2025 results - MarketScreener
NeueHealth, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
NeueHealth Reports Second Quarter 2025 Results - TradingView
NeueHealth Q2 revenue up 45% YoY, serves 694k consumers. - AInvest
NeueHealth Inc. Flashes Rebound Signal in Oversold ConditionEntry Alert Based on Volume Spikes Detected - metal.it
Does NeueHealth Inc. stock perform well during market downturnsBuild wealth faster with consistent growth stocks - Jammu Links News
Should I hold or sell NeueHealth Inc. stock in 2025Capitalize on market trends with confidence - Jammu Links News
Is NeueHealth Inc. stock overvalued or undervaluedGet timely alerts on market opportunities - Jammu Links News
What are the latest earnings results for NeueHealth Inc.Expert guidance for superior capital growth - Jammu Links News
What is NeueHealth Inc. company’s growth strategyExplosive wealth accumulation - Jammu Links News
What drives NeueHealth Inc. stock priceBuild capital through low-risk investments - Jammu Links News
What analysts say about NeueHealth Inc. stockAccelerated wealth expansion - Jammu Links News
Is it the right time to buy NeueHealth Inc. stockDiscover undervalued stocks before they soar - Jammu Links News
What institutional investors are buying NeueHealth Inc. stockAccelerated earnings growth - Jammu Links News
Is NeueHealth Inc. a growth stock or a value stockExplosive earning power - Jammu Links News
What catalysts could drive NeueHealth Inc. stock higher in 2025Build wealth faster with professional insights - Jammu Links News
Why is NeueHealth Inc. stock attracting strong analyst attentionTremendous growth opportunities - Jammu Links News
How many analysts rate NeueHealth Inc. as a “Buy”Get real-time alerts on top stocks - Jammu Links News
What markets is BEAGU expanding into Is NeueHealth Inc. stock a good long term investment option - Jammu Links News
Finanzdaten der Neuehealth Inc-Aktie (NEUE)
Es liegen keine Finanzdaten für Neuehealth Inc (NEUE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
5.88%
0.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):